New York Blood Center
Trained as a cell biologist and having worked as a business development professional in different functions during the past 10+ years, I have in-depth understanding of current R&D approaches, sourced and analyzed new business opportunities, and managed alliance in a rapidly evolving biotech field. I executed commercial strategies for innovative technologies discovered at major medical centers and structured and finalized 100+ collaboration and license agreements. I participated in the launch of biotechnology companies such as Exosomes Diagnostics, Mulleris Pharmaceuticals, XTuit Pharmaceuticals, Lysosomal Therapeutics Inc., Catherex, and RetroSence Therapeutics. Additionally, I participated in implementing and monitoring NIH Blueprint drug development grants for Massachusetts General Hospital and led a drug discovery external alliance program at Novartis.